March 24, 2025 - 20:40

The House Financial Services Committee’s Financial Institutions Subcommittee is set to convene on Wednesday, March 26, to explore potential modifications to the Consumer Financial Protection Bureau (CFPB). This hearing comes amid ongoing debates regarding the agency's effectiveness and its impact on consumers and financial institutions alike.
Lawmakers are expected to examine the CFPB's regulatory framework and its role in safeguarding consumer interests in the financial sector. The discussion will likely address concerns about the bureau’s authority, transparency, and the balance between consumer protection and the operational capabilities of financial institutions.
As the Subcommittee prepares for this important dialogue, various stakeholders, including consumer advocates and financial service providers, are expected to present their perspectives. This hearing could pave the way for significant legislative changes, reflecting the evolving landscape of consumer finance and the need for robust oversight in protecting consumers from unfair practices.
June 3, 2026 - 07:37
Japan finance minister says ready to respond appropriately on forexTOKYO, June 3 - Japanese Finance Minister Satsuki Katayama stated on Wednesday that the government is prepared to take appropriate measures in the foreign exchange market, issuing a fresh warning...
June 2, 2026 - 17:28
Thrifts & Mortgage Finance Stocks Q1 Results: Benchmarking Franklin BSP Realty Trust (NYSE:FBRT)The close of earnings season offers a useful moment to check in on how different sectors are navigating the current economic climate. For investors keeping an eye on thrifts and mortgage finance...
June 2, 2026 - 05:00
HPE expects to achieve 2028 financial targets this year after record quarter on AI boomHewlett Packard Enterprise reported record revenue for its second fiscal quarter on Monday, driven by surging demand for AI data center infrastructure. The strong performance has led the company to...
June 1, 2026 - 02:50
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First QuarterA recent $5.5 million executive departure at Wave Life Sciences has drawn scrutiny following the company`s disappointing first-quarter performance. The clinical-stage biotech, which develops...